7TUJ

NMR solution structure of the phosphorylated MUS81-binding region from human SLX4

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	500 uM [U-100% 13C; U-100% 15N] Phosphorylated MUS81-binding region of human SLX4, 25 mM sodium phosphate, 100 mM sodium chloride, 100 uM EDTA, 100 uM sodium azide	93% H2O/7% D2O	0.125 M	7.4	1 atm	283	Bruker AVANCE III 700
2	2D 1H-13C HSQC aliphatic	500 uM [U-100% 13C; U-100% 15N] Phosphorylated MUS81-binding region of human SLX4, 25 mM sodium phosphate, 100 mM sodium chloride, 100 uM EDTA, 100 uM sodium azide	93% H2O/7% D2O	0.125 M	7.4	1 atm	283	Bruker AVANCE III 700
3	2D 1H-13C HSQC aromatic	500 uM [U-100% 13C; U-100% 15N] Phosphorylated MUS81-binding region of human SLX4, 25 mM sodium phosphate, 100 mM sodium chloride, 100 uM EDTA, 100 uM sodium azide	93% H2O/7% D2O	0.125 M	7.4	1 atm	283	Bruker AVANCE III 700
4	3D HN(CO)CA	500 uM [U-100% 13C; U-100% 15N] Phosphorylated MUS81-binding region of human SLX4, 25 mM sodium phosphate, 100 mM sodium chloride, 100 uM EDTA, 100 uM sodium azide	93% H2O/7% D2O	0.125 M	7.4	1 atm	283	Bruker AVANCE III 700
5	3D HNCO	500 uM [U-100% 13C; U-100% 15N] Phosphorylated MUS81-binding region of human SLX4, 25 mM sodium phosphate, 100 mM sodium chloride, 100 uM EDTA, 100 uM sodium azide	93% H2O/7% D2O	0.125 M	7.4	1 atm	283	Bruker AVANCE III 700
6	3D HNCA	500 uM [U-100% 13C; U-100% 15N] Phosphorylated MUS81-binding region of human SLX4, 25 mM sodium phosphate, 100 mM sodium chloride, 100 uM EDTA, 100 uM sodium azide	93% H2O/7% D2O	0.125 M	7.4	1 atm	283	Bruker AVANCE III 700
9	3D HNCACB	500 uM [U-100% 13C; U-100% 15N] Phosphorylated MUS81-binding region of human SLX4, 25 mM sodium phosphate, 100 mM sodium chloride, 100 uM EDTA, 100 uM sodium azide	93% H2O/7% D2O	0.125 M	7.4	1 atm	283	Bruker AVANCE III 700
8	3D HBHA(CO)NH	500 uM [U-100% 13C; U-100% 15N] Phosphorylated MUS81-binding region of human SLX4, 25 mM sodium phosphate, 100 mM sodium chloride, 100 uM EDTA, 100 uM sodium azide	93% H2O/7% D2O	0.125 M	7.4	1 atm	283	Bruker AVANCE III 700
7	3D HNHA	500 uM [U-100% 13C; U-100% 15N] Phosphorylated MUS81-binding region of human SLX4, 25 mM sodium phosphate, 100 mM sodium chloride, 100 uM EDTA, 100 uM sodium azide	93% H2O/7% D2O	0.125 M	7.4	1 atm	283	Bruker AVANCE III 700
10	3D 1H-15N TOCSY	500 uM [U-100% 13C; U-100% 15N] Phosphorylated MUS81-binding region of human SLX4, 25 mM sodium phosphate, 100 mM sodium chloride, 100 uM EDTA, 100 uM sodium azide	93% H2O/7% D2O	0.125 M	7.4	1 atm	283	Bruker AVANCE III 700
13	3D 1H-13C NOESY aromatic	500 uM [U-100% 13C; U-100% 15N] Phosphorylated MUS81-binding region of human SLX4, 25 mM sodium phosphate, 100 mM sodium chloride, 100 uM EDTA, 100 uM sodium azide	93% H2O/7% D2O	0.125 M	7.4	1 atm	283	Bruker AVANCE III 700
12	3D 1H-13C NOESY aliphatic	500 uM [U-100% 13C; U-100% 15N] Phosphorylated MUS81-binding region of human SLX4, 25 mM sodium phosphate, 100 mM sodium chloride, 100 uM EDTA, 100 uM sodium azide	93% H2O/7% D2O	0.125 M	7.4	1 atm	283	Bruker AVANCE III 700
11	3D 1H-15N NOESY	500 uM [U-100% 13C; U-100% 15N] Phosphorylated MUS81-binding region of human SLX4, 25 mM sodium phosphate, 100 mM sodium chloride, 100 uM EDTA, 100 uM sodium azide	93% H2O/7% D2O	0.125 M	7.4	1 atm	283	Bruker AVANCE III 700

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	700

NMR Refinement
Method	Details	Software
molecular dynamics		CNS

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	CNS		Brunger, Adams, Clore, Gros, Nilges and Read
2	structure calculation	CYANA	2.1	Guntert, Mumenthaler and Wuthrich
3	data analysis	FMCGUI		Lemak and Arrowsmith
4	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
5	peak picking	NMRFAM-SPARKY		Lee, Tonelli, and Markley
6	peak picking	CcpNmr Analysis		CCPN

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.